MedTrace Logo

New Markers of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Sweat

NCT03993600 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-03-24

No results posted yet for this study

Summary

The aim of the study is to identify new biomarkers of CFTR function in sweat and in sweat gland.

Conditions

Interventions

DIAGNOSTIC_TEST

Sweat test (Macroduct Sweat Collection System) and skin biopsy (Punch Biopsy)

three groups: 1. Healthy volunteers 2. Patients with Cystic fibrosis 3. Heterozygous subjects

Sponsors & Collaborators

  • Université de Liège

    collaborator OTHER

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Teresinha Leal, MD, PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-04
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03993600 on ClinicalTrials.gov